A clinical and laboratory databank for patients with Inborn Errors of Metabolism (VICIEM)

VICIEM is a clinical and laboratory databank for patients with Inborn Errors of Metabolism (inherited metabolic diseases). VICIEM consolidates disparate records into a single unified electronic database and includes data on patients treated at the Royal Children’s Hospital (RCH), Melbourne, since 1970.

VICIEM databank was created in order to develop a better understanding of the natural history of these disorders and provide information that can aid in improving prognostication, effectiveness of newborn screening, cost and effectiveness of treatment (including dietary manipulations), and possibly analyses of the correlation between mutations and clinical outcome, where applicable. It is hoped it will serve as an important step towards devising evidence-based therapies.

Study Summary
Study name A clinical and laboratory databank for patients with Inborn Errors of Metabolism
Study abbreviation VICIEM
Current principal investigator/s Avihu Boneh
Current project manager

Avihu Boneh

Primary Institution/s Murdoch Children’s Research Institute - MCRI
Major funding source/s The N E Renton Bequest
Study focus

To develop a better understanding of the natural history of inborn errors of metabolism (inherited metabolic diseases), an important step towards devising evidence-based therapies.

Sampling frame

Patients who presented at the Royal Children’s Hospital, Melbourne, for treatment for an inherited metabolic disease (with records from 1970 – ongoing).

Primary study type Databank / Biobank
Primary participant (at recruitment) Index child
Year commenced

2013

Is this study ongoing? Yes - the study is ongoing
Ongoing recruitment? Yes
Sample size (N)

1668 as of November 2021, ~60 new patients per year

Survey data available? No
Imaging data available? Yes
Linkage to administrative dataset/s? No, no consent to link to administrative dataset(s) obtained
Biosamples available? No
Are data available to others outside study team, with appropriate safeguards and structures in line with the cohort’s ethics and governance processes? Yes
Are there any costs associated with data/sample access for approved requests? There are usually no costs associated with access
Broadest type of participant consent available Extended consent (can be used for future ethically approved research related to this project)
Study Contacts
Principal investigator/s Avihu Boneh
Project manager

Avihu Boneh

Study Contact

Email: avihu.boneh@mcri.edu.au
Address: Metabolic Research
Murdoch Children's Research Institute,
Royal Children’s Hospital
Flemington Road, Parkville
Victoria 3052 Australia